NLRP3 inhibitor (Reistone Bio)

NLRP3 抑制剂（瑞石生物）

Report date: 2025/04/01 15:10:17
NME

Base Information

Drug NameNLRP3 inhibitor (Reistone Bio)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesReistone Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesReistone Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A